November 2025 update

The text of the update Zhittya sent, word for word. Pictures, charts and layout are in the PDF. Open the PDF.

November 17, 2025, Monthly Update

Thanks to All!

Whether it is Oktoberfest in Germany or Thanksgiving in the United States, now is the time of year when we say, Thank you for the blessings we have received this year. I give thanks to all of you who are our partners, our patients, our investors, our supporters, and our friends.

So far, 2025 has been an amazing year for Zhittya and me, and I believe our efforts to treat these horrible diseases for all of humanity have made it a good year. Zhittya is changing health care for all of humanity: 1) We have dosed 230 Parkinson’s disease patients and witnessed material improvement in most, without adverse events. 2) As of November 16, we have now dosed 15 type 2 diabetes patients in our Las Vegas Medical Research Study. Of the first 10 patients, 9 have improved to the point of reducing or eliminating their current diabetes medication. Details of these amazing developments in our type 2 study will be covered in Vika’s section.

Now we plan to add 1) a Medical Research Study for Chronic Wounds and 2) another study for No-Option Heart Disease Patients. Zhittya has an agreement with a heart clinic in the Bahamas (where we have regulatory clearance to proceed) to launch our “No Option Heart Disease Treatments” in January 2026. It is reported that 17 million people die every year from heart disease, and I believe “small vessel heart disease” is responsible for 15 million of those deaths. I believe Zhittya alone has a treatment to lessen the suffering and deaths of those people.

Nothing is more important to me than reactivating the medical indication of “no option heart disease.” Our heart treatment has worked in two human trials in Germany and one in the USA.

Evidence ABC Nightly News broadcast on our success: https://www.youtube.com/watch? v=IPtv_0LWK4k

Our heart treatment has been blocked by the FDA in a ridiculous “Catch-22” that has, in my opinion, allowed millions of people to suffer and die needlessly for the last 15 years. The mood of the world has changed since COVID-19 has shown that the “health-expert class” are no experts. How many so-called health experts think a man can create, carry, and deliver a human baby? Zhittya has done more to improve the health of Parkinson’s disease sufferers in the last 5 years than all the billions of dollars that have gone into Parkinson’s disease research for the last 20 years, which have not demonstrated improvements in Parkinson’s patients’ outcomes. Zhittya has human results for what we have accomplished, helping people recover from Parkinson’s disease. Read the Parkinson's disease patients' comments below.

To prepare for something important that I am working on, I have researched the question of how much money has gone into medical research since 1985 and how many new medicines have made it through the FDA, thereby resulting in reaching sick people since then? The biotech discovery revolution started in the 1970s and then grew substantially for the last 50 years. The USA FDA changed how it handled biological medicine approvals in the late 1970s, and I personally believe that since 1985, nothing has made it through the FDA bureaucracy from then until now. The basic data I have is that since 1985 (40 years ago) about $12 trillion dollars has been spent on medical research, of which $6 trillion was spent in the USA. From our in-depth analysis, I was wrong when I stated I do not believe anything made it through the USA FDA. It appears 5 monoclonal antibodies made it through; however, their medical impact has been marginal at best. When you think of all that money going into medical research and nothing coming out to treat sick people, it is proof that government programs are a waste of money and that the FDA is where new medical projects go to die. Big Pharma has $45 billion in annual sales of diabetes medicines, and yet in 12 years they never saw the many published papers that FGF-1 in the brain reversed type 2 diabetes. They ignored a possible cure for type 2 diabetes for 12 years and let 37 million Americans with type 2 diabetes suffer and die because…?

The “Winds of Change” are upon us now! Here is a link to two articles written by my friend Stephen Moore (author of Trumponomics and an economic advisor to President Trump).

October 14, 2025: New York Post “With Operation Warp Speed II, Trump can Slash Red Tape and Save Lives”

October 20, 2025: “FDA review of drugs is slowing while application delays are growing, analysis finds.”

Read these two stories: medical freedom is coming to us again after 40 years of imprisonment by the FDA.

I wanted to confirm what I believed—that most of the medical research discoveries made in the last 40 years have not reached sick patients. We, tiny Zhittya Genesis Medicine, have a medical treatment to treat the number one cause of death in the world (proven and in published data), “small vessel heart disease,” and for 15 years we cannot advance through the FDA because they have a “Catch-22” requirement that is insanity! We are developing a treatment for brain disorders (Parkinson’s, strokes, dementia, Alzheimer's, and more) without one penny of government grants or assistance, except from the people who want to be treated and their lives improved. Little tiny Zhittya is advancing what may be a cure for type 2 diabetes, and all we face in front of us are barriers after barrier. With each barrier we overcome those obstacles, and we advance. That's what entrepreneurs do! Our 100-person Medical Research Study has had an overwhelming response of people who want to try and reverse their type 2 diabetes. We average about 150 new sign-ups every day, and we have over 4,000 signed up already after a few months. This 100-person study is to help us discover the best dosing to reverse type 2 diabetes. Cadre #1 (5 people) received the same dosage protocol as the type 2 diabetics received in the British Virgin Islands, of which all 25 reversed their diabetes, 100% success. Cadre #2 (5 people) received the same amount of FGF-1, but in 2 days (not 6 days). Cadre #3 (5 people) is being dosed with the same amount of FGF-1; however, all in one day. Cadre #4 to #10 all vary, trying to find what is the best dosing to accomplish the reversal of type 2 diabetes. The last 50 patients will be dosed using whichever dosing protocol proves to be the best dosing that reverses type 2 diabetes. We are trying to use people from the Las Vegas Valley for the first groups since they do not have to travel or stay at a hotel. I hope we have completed this 100-person Medical Research Study to Reverse Type-2 Diabetes by April 2026. Now we are planning a 1,000-person Medical Research Study to Reverse Type-2 Diabetes starting in April 2026 to create a larger amount of evidence that we are really curing type 2 diabetes. If Cadre #3 (one-day dosing) proves to be the best, then people from Seattle and Ohio can fly into Las Vegas, be treated in one day, and then fly home, hopefully cured of type 2 diabetes. Nevada has over 60 million visitors per year. Many are repeat visitors, so I will guess 30 million are unique visitors. I would guess 10 million are young adults and children, leaving 20 million older adults. The Centers for Disease Control (CDC) states 29.2% of people over 65 have type 2 diabetes. So, I will guess 20% of those 20 million have type 2 diabetes, or 4 million people. A few of the people visiting Las Vegas are poor. If 1% of the 4 million coming to Las Vegas visited our clinic to be treated for their type 2 diabetes, that equals 40,000 patients per year. If the wealthiest 5% want to get rid of their type 2 diabetes, that would be 200,000 patients per year. Zhittya has a plan.

It is reported that 25% of all healthcare dollars spent in the United States are spent on diabetes care. You cannot change the world, you cannot cure diabetes, and you cannot take away the barriers that want to protect their $45 billion diabetes drug cartel or make up 25% of all healthcare dollars down to only 2%, since, like polio, type 2 diabetes is cured, they lose billions of dollars. If this task were easy, then someone sane would have done it. You can read many, many papers that say FGF-1 in the brain has reversed type 2 diabetes in animals over the last 12 years. Why didn’t you do it? Why didn’t Big Pharma do it? Why didn’t the National Institute of Health do it? Why has this small, tiny team of warriors at Zhittya accomplished these medical breakthroughs? Because we know if the task was easy, God would have given the mission to someone else. I have an MBA from the University of Southern California (USC). I taught at three universities and have been on over 10 boards of directors of publicly traded companies, and some people wonder why I was not smart enough to not take on this impossible task. My father told me growing up, all great achievements were once impossible, and God only gives the Impossible Task to those people too stupid to quit until they have done it. Thank God I am too stupid to quit!

Another example of medical innovation that is sitting on the shelf. In 2006, a research paper was published where the National Cancer Institute and MD Anderson Cancer Center developed a molecule that eradicated naturally occurring solid cancer tumors within 90 days in pet dogs. In 2010, we were invited to bio- manufacture that molecule since we alone could make it. We made a deal with the National Cancer Institute quickly, and for over a year after that, we could not make a deal with MD Anderson. We gave up trying since they would not accept yes. I believe then and now we have an obligation to humanity to find out if this is real, since it could eradicate the cause of 85% of all cancer deaths in the world. Understand this: I do not know if it will work, but what I know is we have an obligation to find out if it works. My father died of cancer at age 53; no one should die from cancer. It is personal to me. The patent on that molecule expired last year; this discovery to possibly eradicate cancer has sat on the shelf for 18 years. We have produced that molecule, we have conducted animal studies, and I hope in 2026 we will finally have room in our schedule to start testing it in humans. Are we right? Does it work? We do not know; that is why it is called discovery. You cannot discover a new world if you refuse to sail out of your home port.

I am 77 years old. I do not have 40 years to wait while the FDA does not allow any medicines that can extend lives and limit suffering to be frozen in its towers of so- called experts. While the FDA cleared an unproven COVID-19 vaccine with no safety data and a government mandate that I had to take, and they do not clear treatments for heart disease, cancer, and diabetes?

I give thanks to all of you who are our partners, our patients, our investors, and our friends.

Please read Vika’s section below on our journey to treat and, I hope, cure type 2 diabetes. The first 5 people we dosed in September—it is quite amazing what you discover when you start something no one has ever done before. When we started treating Parkinson’s disease patients 3 years ago, our knowledge had grown manyfold, and with each new piece of information, we can modify the treatment procedure to hopefully enhance the outcomes. With the first five type 2 diabetes patients, even simple things like a clipboard would make it easier to handle this paperwork; send someone to the store, and buy some clipboards.

Zhittya may be a very tiny biotech company, but think of the $12 trillion in medical research since 1985, with almost zero treatments for sick people, and Zhittya has treatments for heart disease, brain disorders, type 2 diabetes, chronic wounds, and maybe even cancer, and we have done it with our own money. Who says free market entrepreneurship does not deliver?

Background and Type 2 Diabetes Medical Research 2st Glance Report by Vika & Sergiy Montano

We are thrilled to share the latest developments from our groundbreaking Type 2 Diabetes Research Study, which officially commenced in Las Vegas, Nevada, on September 22, 2025. We have now dosed our first two cadres of patients (10 total patients) as part of a larger planned study involving 100 participants. This phase continues to ensure a smooth rollout. We are observing even more promising indicators that highlight the potential of our innovative approach using FGF-1 to target what we and other researchers hypothesize as the root cause of type 2 diabetes: the degeneration of glucose-sensing neurons in the brain, leading to a loss of control of glucose levels and subsequent insulin resistance.

Central to our monitoring strategy are some of the most advanced continuous glucose monitors (CGMs) available today. These state-of-the-art devices allow remote access to real-time glucose measurements, offering continuous insight into each patient's readings. Data is collected every ~10–15 minutes and securely stored in our custom-built database, a cutting-edge system designed specifically for this study and aligned with the highest standards for clinical research.

Results

Now, approximately eight weeks post-initial dosing for Cadre 1 and four weeks into Cadre 2, the results remain highly encouraging and suggest the transformative potential of FGF-1 therapy. All patients entered the study as confirmed type 2 diabetics, many with longstanding difficulties in managing their condition. We are tracking a range of metrics, including blood glucose trends, medication adjustments, and overall metabolic stability, and the data thus far indicate meaningful improvements across the board.

An Update from Cadre 1:

For Cadre 1, all participants have demonstrated a substantial reduction in their blood glucose levels, as evidenced by continuous glucose monitor (CGM) data. Each participant has experienced at least a 100–150 mg/dL decrease from their baseline peak values, which may reflect FGF-1's normalizing effects on glycemia. It is noteworthy that the CGM's upper detection limit is 400 mg/dL. Among the first five patients in Cadre 1, two consistently exceeded this threshold at baseline.

Those two patients now maintain levels in the 200-290 mg/dL range, with minimal excursions above this, signifying marked improvement.

To date, 80% of participants (4/5) have reduced their diabetes medication by at least half, with some discontinuing it entirely. Notably, several of these participants have encountered their first hypoglycemic episode. We interpret these hypoglycemic events as markers of FGF-1's positive impact on glucose regulation. Fortunately, all have adjusted effectively, maintaining levels within a healthy range.

As shown in the graph above, the red number highlights a patient who experienced a hypoglycemic event. The occurrence of this event during the day may indicate that this patient could wean off her current medication. She has since done so and has maintained normoglycemia despite a ~60% reduction in dosage.

Additionally, two patients reported increased hunger signals compared with baseline, suggesting enhanced metabolic responsiveness and a restoration of normal physiological cues for feeding. These observations suggest not only improved glucose control but also potentially augmented insulin sensitivity and central glucose signaling, as demonstrated by the rapid onset of effects following dosing.

Cadre 2:

Although still in the early stages of treatment, Cadre 2 is exhibiting promising trends. Thus far, all participants have shown decreases in their CGM readings relative to baseline levels. While preliminary, this is a positive indicator. 40% of the participants have experienced their first hypoglycemic event, an occurrence unprecedented in their medical histories. All have adjusted accordingly. One particularly encouraging aspect of patient feedback is the absence of significant glucose excursions after consuming foods previously avoided due to diabetes. Participants report more stable postprandial responses, even with high- carbohydrate or high-sugar meals. This stability implies a potential restoration of endogenous glucose regulatory mechanisms, enabling greater dietary flexibility without the pronounced fluctuations typical of unmanaged type 2 diabetes.

As you can see in this patient's data, for the first time since her type 2 diabetes diagnosis, she recorded a hypoglycemic event. Although this occurred early in the morning, when blood glucose levels are typically lower, the novelty of this event since diagnosis suggests that FGF-1 may exert a normalizing influence on glycemia.

Generally, hourly glucose readings reveal a decline in participants' glucose levels within 4 hours of dosing. We are also observing consistent patterns across both cadres, including reduced frequency of extreme hyperglycemia and hypoglycemia, improved average daily glucose values, and patient-reported enhancements in energy and well-being. These findings align with the hypothesis that FGF-1 rejuvenates critical neural pathways governing glucose homeostasis.

This data from our Nevada cadres builds upon our initial successes and illustrates the remarkable progress at Zhittya Genesis Medicine. As we continue dosing additional patients and accumulating more data, we will keep you informed of our advancements. Stay tuned for further exciting developments in the months ahead!

Vika’s Patients’ comments:

Zhittya has now dosed over 230 Parkinson’s disease patients, 5 stroke patients, 2 dementia patients, 2 autism patients, and more. We have not seen any adverse events, and there is zero pain, as the medicine is sprayed up the nose without breaking the skin. I provide these comments to make you aware of what I believe is an amazing success:

Type 2 Diabetes Patient Comment: From Rock, a patient in our Type-2 Diabetes Study: https://youtube.com/shorts/FpCLpk_OuAw?si=bhQG_rYI-R1XUEW9

Vika Parkinson’s Patients emails

#1) Becky Tue, Nov. 11, 3:06 PM Dear My Wonderful Friends at Zhittya, I just thought you might like to know the progress I am making at this time. I’ve had people telling me that they have been seeing huge changes in me. The people at my church haven’t seen me in a couple of years been able to go to church for quite a while because I couldn’t sit still. My legs would bounce because of the pain and discomfort in them. When we went out to dinner, I couldn’t sit at the table to eat because of same problem, so I would stand at the side of the table to eat my food. I often paced around the restaurant to help ease the discomfort. I had to eat with my left hand because my right side was affected to the point I couldn’t keep food on my spoon. When I tried to, the food would go flying. I found it very difficult and embarrassing to go anywhere. It was very frustrating! I was in the very first trial for Parkinson’s disease over 3 1/2 years ago and I have been aware of many positive changes since using the FGF-1 factor. I now feel comfortable going out in public again! I’ve been able to start going back to church and can sit now in the bench for the full time. I enjoy going out to eat again and I’m not embarrassed because I’m not having to stand up and I can eat my food with my right hand with very little shaking. Last week while I was at physical therapy, my therapists told me they were very impressed with how well I’m doing especially with my balance! They noticed how much stronger I’m getting and that the trimmer is milder. One of the more current improvements that has thrilled me is my handwriting. It’s gotten good enough that I can actually do calligraphy again. It might take me a while to write something, but it’s coming out beautiful! I’m planning on starting to do my artwork again soon! I’ll let you know how that goes. =) I am sending a picture of the calligraphy I did on the back of the Halloween cups I sent my grandkids this past month. I was so proud of how they turned out! It feels so good to be able to use my talent again to make my people happy! I am so grateful to you and your company for the tremendous endeavor you are pursuing! You are helping so many people with so many diseases! What people need to realize and and what I had to learn, is that it takes time! It took time to get sick and for the symptoms show up and it‘s going to takes time for things to reverse! There were times when I wondered if the medicine was working but with patience and encouragement from my husband I hung in there! I’m glad I did because I can really see the changes happening now and so can the people that are around me!

#2)

Nick has his voice back! his normal voice!!! He’s been going to a speech therapist to try to learn how to project his voice cause it had gotten so low; but today he had 13 patients and his voice came back and he was able to speak normally all day long we’re so excited!!!

2nd message about Nick: Vika another change Nick has had such excessive saliva he had trouble not drooling to the point he got some medication from his Neurologist for that, but he has used it for just a short time because that has quit!!! We are so excited for these changes and so very grateful for you and Dan!!! And the work you are doing. Please is there anyway two other dear friends of mine, as well as our Nephew who all have type 2 Diabetes get into the protocol you are doing next year? Our nephew was having terrible time with his feet and has for a few years with horrible neuropathy. He’s the most urgent. I cannot believe the blessings that you and Dan are is so many people and the possibility of so many more!

#3) June (wife of patient)

Hi Vika This is a short note to keep you and Dan in the loop regarding the progress of my husband. He was in your BVI Cohort last May’24 for Parkinson’s. Immediately there was obvious progress after one week of BVI FGF-1 treatments and then for the next eight months it was 2 steps forward and one step back from those BVI improvements. One year ago: Fall ’24 He officially retired from his business only because of Parkinson’s.

September ‘24 RV trip to Yellowstone Nat’l Park with our kids and grandkids.

Then a camping / hunting trip. He realized he was not able to hike and fish and hunt. Parkinson’s took away his hobbies. He still was able to take walks on the beach with me and the dog. Then the first Sunday morning of February ’25. I awoke and found him on the bathroom floor, cold and unresponsive. Fire dept. and Ambulance arrived and he was transported to the Hospital. He had fallen and hit his head then strokes and seizures followed. All stemming from undiagnosed UTI on top of Parkinson’s. After 4wks of hospitalization Drs recommended we take him home or to a facility on hospice care. Now I had to consider planning his funeral. I called Vika and she counseled me to get him home as soon as possible and begin the FGF-1 protocol again. At that time the protocol was FGF1 every three months. Vika advised me of the new protocol, which is every other week. I brought him home where he had full time caregiver in the beginning. Drs sent him home on stroke and seizure Rxmeds. Also needed Ambien for sleep. He learned to walk with a walker and a wheel chair was needed for a while. He couldn’t get on his hands and knees to get a dose of FGF1. We had to get our son and son-in-law to do the dosing in the beginning before new applicators were sent. So, he could then be dosed sitting upright. The following Parkinson’s symptoms he has struggled with for a year prior to the fall. But everything was exasperated by the results of the brain injury from the fall.

He was unable to dress himself, (could not figure out how to lay out a t-shirt and get his hands in the right holes.) or a button up shirt. His food had to cut into bitesize pieces. Swallowing issues. Feeding himself - even a sandwich was very messy. He was unable to grip and hold the sandwich together. Drinking only from a straw or he would wear it.

Morning cup of Coffee was a big challenge even with a Yeti. Evening glass of wine … yes, more challenging. He sat in a recliner chair most of the day and napped. Watched a lot of same channel tv because he “forgot” how to use a tv remote control. He was unable to get himself ready for bed (thank goodness for electric toothbrush, bathing, pjs.)

Over the next Three months: March, April, May. I titrated off stroke & seizure meds and added many supplements and detoxing Traded RX Ambien for WYLD Sleep GUMMIES plus extra CBN10 for sleep. Also, some Melatonin 20mg. This combination seems to do the trick and adjust dosing as needed. This took some getting accustomed to as he had never tried cannabis before. He is sleeping mostly uninterrupted 7-9 hrs each night. Not feeling drugged up in morning. By

Summertime and we were in the swimming pool and he started working out, walking and balance exercises and stationary bike and shooting hoops indoors and the AirHockey table. He daily used Platinum Red Light therapy , weekly acupuncture and a few crazy diet changes. Always looking I found on the internet more physical therapies/activities for Parkinson’s patients.

My husband does not recognize a lot of his improvements over this past year and is disappointed with slow progress. His memories of February March and April are sketchy at best. Fast forward fifteen months from beginning FGF-1 treatments in BVI to September’25 during an appt with the acupuncturist, she reminded him of when he began acupuncture treatments before 2024 BVI - FGF1 and the progress he has made since BVI - FGF1 treatments.

He and his caregiver are walking with his dog one mile everyday around here then back home to ride stationary bike for 45 - 60 min. He does balancing exercises and then puzzles and memory games. Grandkids come here everyday afterschool to play. He laughs with the grandkids and his face doesn’t look so scary now, without his mask (Parkinson’s not Halloween). His cognitive skills have dramatically improved over the past year. He now gets up each morning and bathes and dresses himself before he comes out for morning coffee (drinks from his old favorite mug). He includes himself in our family conversations around the dinner table every Sunday evening. His voice is heard and he is relevant and keeps up with the conversation. His memory is wonderful and shows off every day.

His caregiver said her past 4 patients all had Parkinson’s Disease and have passed away. She has never seen improvements like he is experiencing. She had never heard of ZHITTYA or FGF-1 . Recently she took on another Parkinson’s patient and works for us only a few mornings now during the week for physical therapy, organizing schedules, pills and his companion while I am gone.

I have scolded him about taking risks and falling, worried he can’t get up and I am unable to get him up off the floor without help. The first week of August. he challenged me to sit on the floor and then stand up without using my hands to push myself up. Or for support. Go ahead - try it yourself! I was not able to stand up without using my arms to push myself up . Then he abruptly sat down and proceeded to do sit to stand and he did it three times from the floor without using his hands.

Granted this is not the retirement I planned for us. He said he did not plan it this way either. He still has tremors and rigidity BUT Tomorrow I am driving him to buy a new iPhone ProMax17 (the one biggest screen) He believes he will be able to use it now.

Thank you FGF-1 !

We recognize improvements big and small made since he started FGF-1 a year ago. He has suffered with Parkinson’s Disease and was diagnosed over 9 years ago. Parkinson’s did not show up over night.

We are both grateful. Thank you ZHITTYA and Dan and Vika for your commitment and support in changing lives. We believe

Zhittya’s Medical Research Studies Funding

We have about 80% committed of the $5 million to fund the first 100-person study in Las Vegas. I believe we will be able to close that funding for the Type 2 diabetes study within 60 days. This will be the only opportunity to be part of the Type 2 Diabetes Medical Research Studies funding. Now that we have data that shows it appears to be successful in reversing type 2 diabetes, it reduces the risk. Don’t miss out on the possible 10 times return on your money with a backup guarantee from Zhittya of doubling your money in four years, if you are not happy. I believe that all the investors will be happy.

Also, some of the investors are excited that they might directly be involved in a cure for diabetes. As one investor told me, he would like to tell his grandchildren they will not have diabetes in their lives when they grow up, because he directly contributed to the discovery to eradicate diabetes. He told me in 1955 his father collected dimes, for the March of Dimes to find a cure for polio. His father told him, “Son, you will not have polio, because your daddy helped to defeat it.” He told me, “Dan, I have given a lot of money to charities, and all I have ever gotten back were more letters asking for more money. Dan, I read the Zhittya diabetes updates like it is my own personal medical discovery project. I may know within 12 months that I helped to cure diabetes. Making ten times my money back does not excite me; I have plenty of money. What I want, Dan, is a wall plaque that says, “John XXXXXX was a partner in finding a cure for diabetes.” I said he will get that plaque, and then he clarified: he still wants ten times his money back, also.

With the warm reception we have had from investors about the Type 2 Diabetes Medical Research Funding, I have decided to start the Medical Research Study for “Healing Chronic Wounds.” We are offering the same 10x upside as a royalty on the cash Zhittya earns from the sale of the FGF-1 medicine to heal chronic wounds. The difference is that we will pay a 50% royalty on cash receipts to the investors until they reach 10 times their investment. We are doing this since I believe: (1) we have 40 years of data, which shows me a 99.9% likelihood of success; (2) nonhealing wounds are a major unmet medical need (estimated 6.5 million in the USA every year alone); and (3) the drug is delivered topically, which should allow it to move more quickly to approval. I believe if we start dosing in December 2025 and dose the 100th patient in March 2026 (with an estimated 4 to 5 months to heal the worst of the worst wounds), we should see results by August of 2026. Zhittya should have a wonderful announcement for the millions of people being harmed by a lack of treatment for their non-healing chronic wounds.

Medical Research Studies Funding Investment Opportunity.

If you are interested in learning more about the Medical Research Study Funding investment opportunity (minimum investment of $25,000), please email me at Dan333@aol.com or call me at 702-802-8373.

Besides making money, you can advance medical innovation to benefit millions of people.

Cross Border Medical Tourism

Cross Border Medical Tourism services are for those people who want to be considered for Zhittya’s future clinical trials or its current Medical Research Studies. Cross Border’s focus is to fill all available slots for Medical Research Studies in the British Virgin Islands and The Bahamas while we wait for other clinics to come online.

Cross Border is working on filling the available slots for the next BVI Medical Research Studies (intranasal FGF-1 for Parkinson’s disease) on the following dates:

Cohort #42: December 3 – 8, 2025

Please get in touch with Sam Cross at Cross Border Medical if you wish to be considered for the BVI cohorts. Sam’s email address is:

In addition, if you are interested in participating in a functional MRI brain scan study, which will take place at Washington University in St. Louis, please let Sam know. There is a finite number of slots for the imaging studies. These studies will look at brain blood flow before and after treatment with FGF-1.

Events:

December 8 Lunch Presentation in Boca Raton, Florida with The South Florida Investment Group

Monday December 8, at 12:00 noon: Dan Montano presenting on: Breakthrough Biotech Medicine: Treating the Causes of Death of 65% of all Adults, Heart Disease, strokes, Parkinson’s Disease, Type-2 Diabetes and more.

The luncheon meeting will be at The Capital Grill, 6000 West Glades Rd. Boca Raton, Fl.

If you wish to attend, RSVP to Dan Montano, email address: Dan333@aol.com or call Dan at 702-802-8373. Space is limited, so RSVP ASAP.

December 8–11: Home Offices Investors Annual Summit at the Westin Ft.

Lauderdale Beach Resort

Tuesday, December 9, at 3:30 PM: Dan Montano on: Breakthrough Biotech Medicine: Treating the Cause of Death of 65% of all Adults Conclusion by Dan Montano

Zhittya is thankful to all of you.

I am thankful to my father, who went from the biggest, strongest man in the world to 78 lbs. of skin and bones from his cancer. A man who never cried in his life (no matter the level of pain), because men do not cry. To him begging me to kill him because the pain was so bad from his cancer. He made me hate cancer with a passion. To my friends who died of heart disease. To Sam Cross Sr., my business partner, who became a No Option Heart patient after his second quadruple bypass, and his medical need is what led me to go to Fulda, Germany, where they used FGF-1 to treat No Option heart patients with small vessel heart disease. Each of these miracles that we have discovered was revealed to us by others' suffering. How did Zhittya work so hard to find that we could treat Parkinson’s patients in the British Virgin Islands, because the FDA denied Cynthia the Right to Try FGF-1 for her ALS? In this 27-year journey, for the first 22 years, I was told by all the experts to get in line and wait for the FDA’s blessing, when they got around to it. I spent over $170 million playing the drug development Swamp Game in Washington, DC, with swamp monsters—consultants, lawyers, and lobbyists—and I paid them over $50 million, with zero success. Spending money and accomplishing nothing is not something I like. Cynthia freed my mind to get it done and save lives; I learned not to wait any longer for the “Do-Nothing Health Experts to do Nothing!”

Zhittya has medical treatments (with human published data of success) to change the health outcome for 65% of all deaths in the world today. If our cancer treatment works in humans (we do not know yet), then that is saving the lives of another 17% of the people from death. I will be satisfied if we can save and defer death for 82% of adults.

I am thankful my life is full of things I must do. I cannot imagine, after I die, meeting my father and telling him I failed him and millions of other people.

Zhittya is tiny, but our soul is strong!

May you all be Blessed with Thanks and Grace.

Remember: Fortune favors the bold. You cannot be bolder than a tiny company taking on Big Pharma, the FDA, and the medical establishment for one objective, one reason: we have a duty, an obligation, to save lives and end suffering if we can! Join us!

Thank you!

Dan Montano, CEO Zhittya Genesis Medicine 8683 W. Sahara Ave., Suite 280 Las Vegas, NV 89117 USA 702-802-8373 zgm.care

<https://www.youtube.com/watch?v=IPtv_0LWK4k>

<https://nypost.com/2025/10/14/opinion/operation-warp-speed-ii-can-slash-red-tape-and-save-lives/>

<https://nypost.com/2025/10/14/opinion/operation-warp-speed-ii-can-slash-red-tape-and-save-lives/>

<https://nypost.com/2025/10/14/opinion/operation-warp-speed-ii-can-slash-red-tape-and-save-lives/>

<https://www.statnews.com/pharmalot/2025/10/20/fda-drug-approvals-slowing-rejections-rising/>

<https://www.statnews.com/pharmalot/2025/10/20/fda-drug-approvals-slowing-rejections-rising/>

<https://www.statnews.com/pharmalot/2025/10/20/fda-drug-approvals-slowing-rejections-rising/>

<https://youtube.com/shorts/FpCLpk_OuAw?si=bhQG_rYI-R1XUEW9>

[mailto:Dan333@aol.com](mailto:Dan333@aol.com)

[mailto:Dan333@aol.com](mailto:Dan333@aol.com)

<https://www.zgm.care/>